Skip to main content

Exascale Labs Holdings Inc.

corporate_fare Company Profile

Exascale Labs Holdings Inc.

XLAB·NASDAQ·Technology·CIK 0002109869

Exascale filed to register up to 12.35 million Class A shares for resale by selling securityholders from its SPAC merger — no new money to the company, but a large block of insider stock becomes tradable.

Exascale Labs Holdings Inc. (NASDAQ:XLAB) is a publicly traded company in the Technology sector. Wiseek has independently scored 7 items for XLAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for XLAB spans S-1, 8-K, 8-K/A, 10-K.

Recent high-impact activity:

  • Exascale Registers 12.35M Shares for Resale by SPAC-Era Holders
  • Exascale Labs Signs $8.2M NVIDIA B300 GPU Server Contract With Sunon Inc.
  • Exascale Labs Reports 111% Revenue Growth to $14.8M and $300M Pipeline in First Post-Merger Results
  • Exascale Labs Files First Post-Merger Financials: $12.2M Net Loss, Going Concern Resolved
  • Exascale Labs' First 10-K Reveals $12.2M Loss, Going-Concern Doubt, and Material Weaknesses

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$14.82M
Net Income
-$12.16M
Diluted EPS
-$8108.26
Op. Cash Flow
-$2.75M
Gross Profit
$2.42M
Operating Income
-$4.8M
Cash & Equivalents
$2.69M
Debt / Equity
0.00×
Net Margin
-82.1%
Shares Outstanding
1.5K sh
Source: 10-K · filed 2026-09-28 · accession 0001829126-26-010462

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 39,229 shares in XLAB as of the October 15, 2026 settlement, a 10.4% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 6, 2026, 75.1% of XLAB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)39,229 shares as of October 15, 2026
Change vs prior period▼ 10.4%
Days to cover1.00 at avg daily volume of 1,517,065
Daily short volume (FINRA facilities)75.1% of 487,202 shares on November 6, 2026
5-day average short volume65.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for XLAB, detected from its recent SEC filings.

1 shelf registration

Resale Registration of 12.35M Shares · No Proceeds to the Company

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

$1.5
52-week range · as of 2026-10-30 $0.7777 – $11.17
Market cap
$96.5M
Volume
1.2M (0.1× avg)
3-mo avg 11.9M
Live data · 2026-11-08 04:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XLAB - Latest Insights

XLAB
Oct 30, 2026, 4:21 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $2.85
Real-time Price: $1.50 info
Change: -$1.35 (-47%) info
Market Cap: $96.502M info
XLAB
Oct 14, 2026, 8:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8947
Real-time Price: $1.50 info
Change: +$0.6053 (+68%) info
Market Cap: $96.502M info
XLAB
Sep 28, 2026, 5:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.20
Real-time Price: $1.50 info
Change: -$0.700 (-32%) info
Market Cap: $96.502M info
XLAB
Sep 28, 2026, 1:18 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Updated Sep 28, 4:32 PM ET — Exascale signed a non-binding LOI with Compal to jointly develop a U.S.-based native 800 VDC validation platform for next-generation GPU sy…
Price at Filing: $2.28
Real-time Price: $1.50 info
Change: -$0.780 (-34%) info
Market Cap: $96.502M info
XLAB
Sep 28, 2026, 1:17 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $2.28
Real-time Price: $1.50 info
Change: -$0.780 (-34%) info
Market Cap: $96.502M info
XLAB
Sep 14, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.55
Real-time Price: $1.50 info
Change: -$2.05 (-58%) info
Market Cap: $96.502M info
XLAB
Sep 02, 2026, 10:55 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.40
Real-time Price: $1.50 info
Change: -$1.90 (-56%) info
Market Cap: $96.502M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets